Brinker Capital Investments, LLC Vertex Pharmaceuticals Inc Transaction History

Brinker Capital Investments, LLC

$5.01 Billion
Q4 2022

A detailed history of Brinker Capital Investments, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 7,925 shares of VRTX stock, worth $3.73 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

7,925

Previous 9,183 13.7%

Holding current value

$3.73 Million

Previous $2.66 Million 13.95%

% of portfolio

0.05%

Previous 0.05%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$285.76 - $321.48 $359,486 - $404,421	-1,258 Reduced 13.7%	7,925 $2.29 Million
Q3 2022 Nov 01, 2022	SELL	$273.83 - $305.53 $131,438 - $146,654	-480 Reduced 4.97%	9,183 $2.66 Million
Q2 2022 Jul 18, 2022	SELL	$234.96 - $292.55 $873,581 - $1.09 Million	-3,718 Reduced 27.79%	9,663 $2.72 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $9,521 - $11,221	-43 Reduced 0.32%	13,381 $3.49 Million
Q4 2021 Feb 08, 2022	BUY	$177.01 - $223.45 $407,300 - $514,158	2,301 Added 20.69%	13,424 $2.95 Million

Q2 2021 Aug 03, 2021	BUY	$187.49 - $221.1 $6,749 - $7,959	36 Added 0.32%	11,123 $2.24 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $2.4 Million - $2.8 Million	-11,596 Reduced 51.12%	11,087 $2.38 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $2.66 Million - $3.54 Million	12,838 Added 130.4%	22,683 $5.36 Million
Q3 2020 Dec 03, 2020	BUY	$255.65 - $303.1 $2.52 Million - $2.98 Million	9,845 New	9,845 $2.68 Million
Q1 2020 May 13, 2020	SELL	$199.77 - $247.81 $14,383 - $17,842	-72 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$166.71 - $223.91 $833 - $1,119	5 Added 7.46%	72 $16,000
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $72,476 - $81,571	-436 Reduced 86.68%	67 $11,000
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $37,695 - $43,594	229 Added 83.58%	503 $92,000
Q1 2019 May 14, 2019	BUY	$163.73 - $194.7 $44,862 - $53,347	274 New	274 $50,000

Others Institutions Holding VRTX

# of Institutions

1,623

Shares Held

222M

Call Options Held

1.35M

Put Options Held

1.49M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $121B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Vertex Pharmaceuticals Inc Transaction History